Wanbury Limited (BOM:524212)
India · Delayed Price · Currency is INR 180.65
-18.00 (-9.06%)
At close: Jan 21, 2026
Wanbury Market Cap
Wanbury has a market cap or net worth of 6.18 billion as of January 23, 2026. Its market cap has decreased by -31.48% in one year.
Market Cap
6.18B
Enterprise Value
8.04B
Revenue
6.31B
Ranking
n/a
PE Ratio
11.84
Stock Price
180.65
Market Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 6.18B, an increase of 249.75%. That is a compound annual growth rate of 6.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 6.18B | -21.99% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 10.10B |
| Fermenta Biotech | 9.74B |
| Lincoln Pharmaceuticals | 9.60B |
| Bharat Parenterals | 8.05B |
| Anuh Pharma | 7.34B |
| Accent Microcell | 7.13B |
| Fredun Pharmaceuticals | 7.11B |
| Kopran | 6.56B |